Elena M Umland

Summary

Affiliation: Thomas Jefferson University
Country: USA

Publications

  1. pmc The role of transdermal estrogen sprays and estradiol topical emulsion in the management of menopause-associated vasomotor symptoms
    Amy M Egras
    Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Gen Med 3:147-51. 2010
  2. pmc Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
    Elena M Umland
    Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Womens Health 4:305-19. 2012
  3. ncbi request reprint Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms
    Elena M Umland
    Jefferson College of Pharmacy, Thomas Jefferson University, 130 South 9th St, Philadelphia, PA 19107, USA
    J Manag Care Pharm 14:14-9. 2008
  4. ncbi request reprint Outpatient management of anticoagulation therapy
    Anne L du Breuil
    Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Am Fam Physician 75:1031-42. 2007

Collaborators

  • Amy M Egras
  • Anne L du Breuil

Detail Information

Publications4

  1. pmc The role of transdermal estrogen sprays and estradiol topical emulsion in the management of menopause-associated vasomotor symptoms
    Amy M Egras
    Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Gen Med 3:147-51. 2010
    ..Two newer formulations are transdermal estrogen spray and estradiol topical emulsion. This review evaluates the current literature assessing the use of these two newer formulations for the treatment of VMS associated with menopause...
  2. pmc Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
    Elena M Umland
    Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA
    Int J Womens Health 4:305-19. 2012
    ..The variety of treatment options for VMS will be discussed. Focus will be given to the role of desvenlafaxine as a treatment option for VMS management...
  3. ncbi request reprint Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms
    Elena M Umland
    Jefferson College of Pharmacy, Thomas Jefferson University, 130 South 9th St, Philadelphia, PA 19107, USA
    J Manag Care Pharm 14:14-9. 2008
    ..Vasomotor symptoms (VMS), such as hot flashes and night sweats, are the most bothersome symptoms of menopause and affect an estimated 75% of women aged over 50 years...
  4. ncbi request reprint Outpatient management of anticoagulation therapy
    Anne L du Breuil
    Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Am Fam Physician 75:1031-42. 2007
    ..Patients at higher risk of thromboembolization should stop warfarin therapy four to five days before surgery and start LMWH or unfractionated heparin two to three days before surgery...